# Can flow cytometry be an alternative method for the detection of antimicrobial resistance?

**Authors:** Ozel Yuruker, Emrah Güler, Kaya Süer, Meryem Güvenir

PMC · DOI: 10.4314/ahs.v24i3.8 · African Health Sciences · 2024-09-01

## TL;DR

This study explores using flow cytometry as a fast and reliable method to detect antibiotic resistance in E. coli and P. aeruginosa.

## Contribution

The study introduces a novel flow cytometry-based approach for rapid detection of ESBL and MDR bacteria.

## Key findings

- Flow cytometry efficiently identified cells with damaged membranes after antibiotic exposure.
- The method detected ESBL E. coli and MDR P. aeruginosa with high accuracy.
- CLA index values above 1.5 indicated resistance in a majority of tested isolates.

## Abstract

The inappropriate use of antibiotics may cause antibiotic resistance, cause side effects, and eventually cause an increase in healthcare costs. This study aimed to determine a flow cytometry-based test to detect ESBL E. coli and MDR P. aeruginosa in a short time.

The study included 25 E.coli isolates and 25 P.aeruginosa isolates identified by Phoenix TM 100 automated system [Becton Dickinson, USA]. In the flow cytometric method, the percentages of death cells exposed to cephalosporin including ceftazidime [CAZ] or cefotaxime [CTX] and clavulanic acid [CLA] combination, were compared with death cells exposed only to a cephalosporin [CAZ or CTX]. CLA index values [CAZ-CLA and CTX-CLA indices] were obtained for CTX and CAZ. Index values that were higher than 1.5 just for one cephalosporin were accepted as positive.

Cell viability was performed after 1-hour exposure to the drugs. When PI staining was applied to ESBL-treated and MDR-treated bacteria, 65% and 85% had nonviable membranes, indicating the method efficiently identified only cells with damaged membranes.

Flow cytometry is a rapid and reliable method for the detection of ESBL and MDR in clinical microbiology laboratories

## Linked entities

- **Chemicals:** cephalosporin (PubChem CID 25058126), ceftazidime (PubChem CID 5481173), cefotaxime (PubChem CID 5742673), clavulanic acid (PubChem CID 5280980)

## Full-text entities

- **Genes:** ESBL [NCBI Gene 13906541]
- **Diseases:** MDR (MESH:D018088)
- **Chemicals:** cephalosporin (MESH:D002511), CAZ (MESH:D002442), PI (MESH:D010716), clavulanic acid (MESH:D019818), CLA (-), cefotaxime (MESH:D002439)
- **Species:** Escherichia coli (E. coli, species) [taxon 562], Pseudomonas aeruginosa (species) [taxon 287]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12327143/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12327143/full.md

## References

15 references — full list in the complete paper: https://tomesphere.com/paper/PMC12327143/full.md

---
Source: https://tomesphere.com/paper/PMC12327143